Adrenaline surged through Julian’s veins, a cold, hard current, even as the last echoes of Anya’s confession hung in the air. Elara. Her name, a desperate plea, resonated with every beat of his heart. His mind, usually a fortress of logic, spun with a potent mix of anger and fierce determination. He would save her sister. He would tear down any obstacle. Seconds later, Julian was already on the phone. His voice, usually calm and measured, was clipped, authoritative. "Get me Dr. Aris Thorne. Immediately. No, don't tell me he's busy. I don't care if he's in surgery. Pull him out." He paced the penthouse living room, the city lights a blur outside the panoramic windows. Anya watched him, her eyes wide, still fragile from her ordeal. "The procedure you mentioned," Julian continued into the receiver, his tone leaving no room for argument. "The experimental stem cell treatment. I need a full brief on it. Every detail. And I need it fast-tracked. Thorne Industries will fund it. Whatever it costs." He hung up, then dialed another number. "Richard. I need a private jet prepared. For immediate departure. To Zurich. And contact my medical team. Inform them they're traveling. Pack everything they might need for a complex pediatric case." Anya swallowed, her voice barely a whisper. "Julian... it's too much. I can't ask you for this." He turned, his gaze intense. "You didn't ask. I'm doing it. Now, tell me everything. Every doctor, every hospital, every detail you held back. We leave at dawn." For the next few hours, Julian meticulously absorbed every piece of information Anya provided. He made calls, pulled strings, and orchestrated a rapid response that would have seemed impossible to anyone else. His corporate network, a web of influence reaching across continents, hummed to life, all focused on one objective: Elara. During one of these urgent calls, a familiar name surfaced from the depths of a secure Thorne Industries database. Dr. Elias Vance, the head of the Zurich research facility, mentioned an unusual expenditure flag on a recent grant application for experimental pediatric treatments. It was a minor anomaly, easily dismissed, but Julian's instincts bristled. "Unusual how?" he pressed, leaning into the speakerphone. "A significant sum, sir," Vance explained, his voice strained. "Disbursed to an external consultant, Mr. Harrison, for 'advisory services' related to similar trials. Except Mr. Harrison has no medical background. And the grant was ultimately denied for lack of viable candidates." Julian's jaw tightened. Harrison. The same board member who had originally blocked Anya's project, claiming it was too risky, too unproven. Harrison, whose public stance was always about fiscal prudence and strict adherence to established protocols. "Access Harrison's full file," Julian ordered, his voice dangerously low. "Every communication, every financial transaction, every meeting he's had in the last two years. Cross-reference it with any project denials or delays related to experimental treatments. Specifically look for anything connected to the pediatric division." The data streamed in, overwhelming in its volume, yet Julian's focus was laser-sharp. He sat at his custom-built workstation, multiple screens displaying dense spreadsheets and encrypted communications. He wasn't just saving Elara anymore; a predator had shown its teeth, and it was inside his own house. Discrepancies began to emerge. Harrison’s 'advisory services' payments were routed through shell corporations. His rejection of Anya’s initial funding request, framed as a concern for financial stability, suddenly looked like deliberate obstruction. But why? Julian remembered the internal memo from months ago. A push to restructure the R&D division, placing more power with a select few board members, ostensibly to streamline operations. He had dismissed it as typical corporate jockeying. Now, it felt like a prelude. Further digging revealed Harrison wasn't acting alone. Encrypted emails, initially overlooked, contained veiled instructions, subtle coercions. Harrison was a pawn, a useful idiot, too greedy to question the source of his unexpected wealth. The real target wasn't just Elara's treatment. The real target was Julian himself. The denial of promising experimental treatments, the attempts to consolidate power, the subtle undermining of his leadership from within – it all pointed to a coordinated effort. His merger protocols, designed to optimize and expand Thorne Industries, had been met with increasing, yet subtle, resistance. He had attributed it to conservative board members, fearful of change. Now he understood. They weren’t afraid. They were plotting. His fingers flew across the keyboard, bypassing layers of security. He accessed the archived minutes of a private, unscheduled board meeting, one he hadn't been informed of. The subject line was innocuous: "Quarterly Performance Review Strategy." But the content was anything but. Discussions focused not on improving performance, but on 'realigning leadership vision.' Phrases like 'shareholder confidence' and 'strategic redirection' peppered the dialogue, all thinly veiled euphemisms for a vote of no confidence. Julian felt a cold dread settle in his gut. The board member he suspected was manipulating Harrison. He searched for the primary architect of the meeting, the one whose name appeared most frequently in the preparatory discussions. It was a name that made his blood run cold. A name synonymous with Thorne Industries for decades. A name that had always projected an image of unwavering loyalty and fierce protection of the company's legacy. His eyes scanned the leaked document, a grim realization dawning. The architect of this subtle, insidious coup, the puppet master behind Harrison's actions, the one directly linked to Anya’s initial struggle for Elara's life, was not just a powerful betrayer. It was a betrayer far closer than he ever imagined. His mentor, Edward Thorne. The founder’s son.

Chapter 45: The Unseen Enemy